Diet has been investigated in relation to its ability to promote cognitive function. However, evidence 37 is currently limited and has rarely been systematically reviewed, particularly in a mild cognitive 38 impairment (MCI) population. This review examined the effect of diet on cognitive outcomes in MCI 39 patients. A total of five databases were searched to find randomised controlled trial (RCT) studies, 40 with diet as the main focus, in MCI participants. The primary outcome was incident dementia and/or 41 Alzheimer's disease (AD) and secondary outcomes included cognitive function across different 42 domains using validated neuropsychological tests. Sixteen studies met the inclusion criteria. There 43 was a high degree of heterogeneity relating to the nature of the dietary intervention and cognitive 44 outcomes measured, thus making study comparisons difficult. Supplementation with vitamin E (one 45 study, n 516), Ginkgo biloba (one study, n 482) or Fortasyn Connect (one study, n 311), had no 46 significant effect on progression from MCI to dementia and/or AD. For cognitive function, the 47 findings showed some improvements in performance, particularly in memory, with the most 48 consistent results shown by B vitamins, including folic acid (one study n 266), folic acid alone (one 49 study, n 180), DHA and EPA (two studies, n 36 and n 86), DHA (one study, n 240) and flavonol 50 supplementation (one study, n 90). The findings indicate that dietary factors may have a potential 51 benefit for cognitive function in MCI patients. Further well-designed trials are needed, with 52 standardised and robust measures of cognition to investigate the influence of diet on cognitive status. 53 54 Background 55
carbohydrate diet (12) , supplementation with Fortasyn Connect (Souvenaid) (33) and vitamin E (31) 279 showed no significant difference in cognitive function tests between groups at study completion. 280 There was a significant improvement in comparison with placebo at six months for those consuming 281 vitamin E supplements (p<0.05) (31) . However, thereafter, this significant difference was not 282 maintained beyond this time point. As shown in table 3, five of the 16 (31%) included studies measured the domain of attention. 286 Nutritional counselling vs standard care showed no significant change in attention between groups 287 after 12 months (37) . Whereas, cocoa flavonol supplementation (34) , significantly better scores for trail 288 making test, part A (p = <0.05) were reported among participants who received HF and IF treatments 289 in comparison to the LF group. In addition, the time required to complete the trail making task, part 290 A significantly changed during the duration of the study (p=<0.0001) (34) . DHA+EPA 291 supplementation (27) (one study) showed a significant improvement in digit span score from baseline 292 to 12 months in the fish oil group vs placebo (p = <0.0001) (27) . However, there was no significant 293 treatment effect reported between the fish oil and placebo groups for any of the other measures of 294 attention (27) . Supplementation with DHA only (30) showed significant improvements in digit span score 295 in comparison to the placebo (p=<0.0001). However, a third study with DHA+EPA 296 supplementation (29) found no significant differences between groups for attention. Two of the 16 (13%) studies measured the cognitive domain of language (table 3) . There were no 300 significant differences between groups for nutritional counselling with calorie restriction (37) . For 301 vitamin E supplementation (31) , there was a significant difference in score from the baseline value 302 between groups at 6 months (p = <0.05), 12 months (p = <0.05) and 18 months (p = <0.05), however, 303 thereafter this significant difference was not maintained until intervention completion (36 months) (31) .
305
Visuospatial skills 306 Four studies (25%) measured the cognitive domain of visuospatial skills (table 3) . Supplementation 307 with folic acid was the only study to show a significant interaction effect between groups for 308 visuospatial skills (p =0.03) (24) . In addition, higher baseline homocysteine levels were associated with 309 poorer cognitive performance on the block design test at the end of the intervention in comparison 310 with the placebo (estimate value = −0.079, p = <0.001) (24) . Fish oil supplementation with concentrated 311 DHA+EPA (27) , DHA (30) or vitamin E supplementation (31) did not show any significant differences 312 between groups.
Global Cognitive Function 314
For cocoa flavonol supplementation (34) (supplementary material table 2) , there was no significant 315 change in MMSE score between the HF, IF or LF treatment groups over the duration of the study (p 316 = 0.13). However, results also showed that the composite cognitive Z score significantly changed 317 during the study (p=<0.0001). The cognitive Z score at the end of the study follow-up was 318 significantly (p=<0.05) better in the HF group in comparison to the LF group (34) . Vitamin B 319 supplementation (25) indicated no significant effect of treatment (p=0.57) on global cognition as 320 measured by MMSE. However, analysis did show that those who had high baseline concentrations 321 of homocysteine and were treated with B vitamins, were 1.58 more likely to provide a correct answer 322 on the MMSE test than the placebo group (p <0.001). However, there was no significant difference 323 for those with low baseline homocysteine, between the B vitamin or placebo groups. Similarly, fish 324 oil supplementation (27) (one study) showed no statistically significant differences between groups for 325 cognitive function as measured by the MMSE. Furthermore, vitamin E supplementation (31) at 6 326 months intervention showed a significant difference in comparison with placebo for overall cognitive 327 function calculated by a composite Z score (p=<0.01). However, at 36 months this significant 328 difference between groups was not maintained. The quality (22) of the 16 included studies varied, with eight studies achieving the maximum total score 332 of 5 (25) (26) (27) (28) 30, 31, 33, 34) (supplementary material table 3) . Thus, it was deemed that these studies stated 333 appropriate randomisation processes, were clearly indicated as double blinded and the authors 334 accounted for any participant withdrawals during the study. Two studies (12, 38) scored one on the Jadad 335 scale (22) and stated that participants were randomised however did not specify the randomisation 336 process, if double-blinding took place and if any participant withdrawals occurred. Low risk of bias 337 scores (23) were allocated for selection bias (n=9) (24) (25) (26) (27) (28) 30, 31, 33, 34) , performance bias 338 (n=7) (25, 26, 28, 29, 30, 33, 34) , attrition (n=9) (24, 25, (27) (28) (29) (30) 33, 34, 37) and detection bias (n=6) (24, 26, 30, 33, 34, 37) 
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(supplementary material table 4). A high risk score was documented for detection bias (n=3) (12, 38) 340 and performance bias (n=2) (12) as there were no details provided of any double blinding method used. The aim of this systematic review was to examine the effect of diet, either alone or in combination 344 with lifestyle and/or cognitive strategies, on cognitive health outcomes in patients with MCI. Together 345 with the limited number of RCTs conducted and the heterogeneity of the studies in this review, a 346 narrative synthesis of the findings was implemented. Studies varied greatly in terms of the nature of 347 dietary intervention and cognitive outcome measures used. Furthermore, there were no studies that measured the effectiveness of lifestyle and/or cognitive strategies in combination with their dietary 349 intervention. Overall, it was evident that the findings were inconsistent across the studies and do not 350 provide clear evidence to support the effect of any specific diet or dietary component on cognition in 351 MCI patients.
353
Diet has been suggested to have a significant association with cognitive decline and progression to 354 dementia, particularly showing a protective role against the harmful effects of neuro-inflammation 355 and oxidative stress (40) . Although the pathways related to their role are complex and variable 356 throughout the literature (14, 15, 16, 41) it is thought that antioxidants in foods such as fruit and vegetables 357 help to reduce oxidative stress levels in the brain and n-3 PUFAs in foods such as oily fish, are 358 additionally linked to reduced inflammation (8) . There are plausible suggestions to support these 359 mechanisms by the results of this review. There were some improvements in cognitive function, 360 particularly in the domain of memory, reported for polyphenol compounds (e.g. cocoa flavonols (34) ), 361 fish oil supplementation with concentrated DHA+EPA (27, 28) or DHA alone (30) and beverages which 362 are high in these bioactive, antioxidant properties e.g. Cocord grape juice (35) and wild blueberry 363 juice (36) . However, some of these studies either had small, potentially underpowered sample sizes, 364 used a limited number of cognitive tests to measure outcomes or had shorter intervention durations 365 therefore these results should be interpreted with caution. As mentioned, antioxidant compounds such as vitamins A, C and E have a role in regulation of 369 oxidative stress, a pathway linked with neurodegeneration and cognitive decline (42) . However in this 370 review, diet supplementation with vitamin E (31) had no significant effect on progression from MCI to 371 dementia and/or AD or on cognitive function at intervention completion. Furthermore, meta-analyses 372 have reported no significant effect of vitamin E on cognitive function outcomes (43, 44) . The particular 373 form of vitamin E used could have an influence on the impact of this nutritional component on 374 cognitive decline, with research suggesting total tocopherol plasma concentrations rather than single 375 tocopherols may be more valuable at predicting cognitive impairment, particularly AD (45) . 376 Furthermore, as we consume foods in complex patterns, resulting in ingestion of combinations of 377 various forms of vitamin E, it may be more beneficial to focus research efforts away from single 378 forms and follow a more holistic investigation (15) . In this review, supplementation with cocoa 379 flavonols (34) showed better cognitive performances for those who received higher flavonols 380 concentrations compared to lower concentrations. There are suggestions in the literature that 381 flavonoids may exert their neuroprotective properties in a similar mechanism to antioxidants in the 382 body (46) . However, further indications suggest that flavonoids may have a more prominent role in the regulation of neuronal signalling pathways (47) or neuro-inflammation (48) . It is clear that further 384 research is required to fully explore the mechanism of action of flavonoid compounds and investigate 385 the potential role they may have in protecting against cognitive decline (49) . 386 specialised cognitive test battery that can be used to measure change in cognition, particularly within 524 an MCI population. Furthermore, change in cognition requires time, more rigorous examinations and 525 evaluation by clinical specialist (79) . These are all important considerations for future intervention trials 526 going forward. Observational study design; Pilot studies, when a paper clearly stated that the research was a "pilot study"
Intervention Dietary Intervention either diet alone (a dietary pattern or dietary supplements) or in combination with lifestyle and/or cognitive strategies
Medical type intervention in conjunction with either a diet/lifestyle/cognitive intervention with undifferentiated results
Control
Control interventions that were not expected to have specific risk-modifying effects; Control arms would typically involve no intervention, usual diet or placebo.
Studies with no comparator, placebo or control
Diagnosis of MCI
Diagnosis of MCI was necessary by a medical physician or according to internationally accepted and validated classifications or criteria "Memory problems" or "self-reported memory complaints" and no clear diagnosis of MCI; A diagnosis of dementia or any other form of cognitive impairment other than MCI, unless results for MCI participants were presented separately; "Cognitively healthy adults" Participants Community dwelling participants; No restrictions made based on gender or age Individuals who were hospitalised, in a rehabilitation or long-term care facility; Participants with psychiatric problems e.g. depression or any significant medical comorbidity, or history of, a comorbid condition that may alter performance on cognitive tests, e.g. stroke, head injury, Parkinson's disease, learning disability et al., 2012 (25) 0.8mg folic acid, 0.5mg vitamin B12 and 20mg vitamin B6 vs placebo HVLT-R (subgroup analyses, with baseline tHcy levels) CERAD (subgroup analyses, with baseline tHcy levels)
The odds of correctly remembering a word from the list of 12 in the HVLT test were 69% greater for a person in the high tHcy group if they were taking B vitamins than if they were taking placebo (OR =1.69) The average number of words was 9.4% greater at follow up in those on B vitamin treatment in the high tHcy group, compared with the placebo (OR=0.09)   -Carter et al., 2011 (38) High fat/high GI diet vs Low fat/ low GI diet
Bayer

Brief Visuospatial Memory Test
Story recall
Word list aMCI Low diet baseline mean score 7.39 (SEM 0.71) -week 4 mean score 8.31 (SEM 0.62); aMCI high diet baseline mean score 8.27 (SEM 0.66) -week 4 mean score 8.40 (SEM 0.58); Healthy controls High diet baseline mean score 9.89 (SEM 0.85) -week 4 mean score 9.56 (SEM 0.74); Healthy controls low diet baseline mean score of 8.27 (SEM 0.77) -week 4 mean score 9.82 (SEM 0.67) aMCI Low diet baseline mean score 18.48 (SEM 1.43) -week 4 mean score 21.46 (SEM 1.70); aMCI High diet baseline mean score 20.37 (SEM 1.31)week 4 mean score 22.30 (SEM 1.59); Healthy controls High diet baseline mean score 22.69 (SEM 1.7 4)-week 4 mean score 23. 19 (SEM 2.04); Healthy controls Low diet baseline mean score 21.09 (SEM 1.55) -week 4 mean score 19.90 (SEM 1.95) aMCI Low diet baseline mean score 11.62 (SEM 0.76) -week 4 mean score 11.77 (SEM 0.80), aMCI High diet baseline mean score 11.33 (SEM 0.71); Healthy controls Low diet baseline mean score 13.27 (SEM 0.93) -week 4 mean score 13.27 (SEM 0.96), healthy controls High diet baseline mean score 12.79 (SEM 0.92) -week 4 mean score 13.67 (SEM 0.95) ---Krikorian et al., 2012 (12) High carbohydrate vs a very low carbohydrate Trail making test, part B V-PAL Intervention (pre-intervention mean score 79.2 seconds vs post intervention mean score 82.9 seconds, F(1, 20) = 0.46, p = 0.50) Control (no detail) Intervention (pre-intervention mean score 11.8 seconds vs post intervention mean score 14.6 seconds, F(1, 20) = 6.45, p = 0.01); Control (no detail) --RAVLT, Rey Auditory Verbal Learning Test; SD, Standard Deviation; HVLT-R, Hopkins Verbal Learning Test -Revised; tHcy, Total Homocysteine; GI, Glycaemic Index; aMCI, amnesic Mild Cognitive Impairment; SEM, Standard Error of the Mean; VPAL, Verbal Paired Associates Learning; CVLT, California Verbal Learning Test; CrPic, Chromium Picolinate; CDT, Clock Drawing Test; NTB, Neuropsychological Test Battery; *Statistically significant difference p≤0.05 within group; **Statistically significant difference p≤0.001 within group; Statistically significant difference (p≤0.05) between intervention & control groups at study completion; -No statistically significant difference between intervention & control at study completion; † Statistically significant difference between intervention & control at stated time-point 30 , 2010b (36) Wild Blueberry juice supplementation vs placebo V-PAL CVLT Intervention (baseline mean score 9.3 vs week 12 mean score 13.2*); Control (no detail); ANCOVA analysis intervention vs control F(1,13) = 5.58 Intervention (baseline mean score 7.2 vs week 12 mean score 9.6*); Control (no detail); ANCOVA analysis intervention vs control F (1,13) Intervention mean change at 24 months, 0.003 (SD 0.569); Control mean change at 24 months -0.130 (SD 0.619) Intervention mean score 12.28 (SD ±3.56); Control mean score 10.82 (SD±2.62) Intervention mean score 13.44 (SD±3.66); Control mean score 10.25 (SD±3.42) Intervention mean score (month 1, 17.46 (SD 4.52) ); Control mean score (month 1, 19.38 (SD 4.65) ) Intervention mean score (month 1, 4.85 (SD 2.91) -month 4, 4.34 (SD 2.74)); Control mean score (month 1, 5.23 (SD 2.63) -month 4, 4.65 (SD 2.79)) Intervention mean score (month 1, 8.92 (SD 2.06) -month 4, 8.38 (SD 2.30)); Control mean score (month 1, 9.00 (SD 2.80) -month 4, 8.00 (SD 2.55)) Intervention mean score (month 1, 11.58 (SD 2.19 ) -month 4, 12.77 (SD 2.67); Control mean score (month 1, 11.50 (SD 2.60) -month 4, 11.85 (SD 1.95)) -  ----Executive Function Lee et al., 2013 (27) Intervention (baseline mean score 5.5, 95% CI 3.723-7.218 -12 months mean score 5.5, 95% CI 3.723-7.218); Control (baseline mean score 4.9, 95% CI 3.254-6.634 -12 months mean score 4.9, 95% CI 3.254-6.634) Intervention (baseline mean score 7.3, 95% CI 6.810-7.880 -12 months mean score 7.8, 95% CI 7.142-8.477); Control (baseline mean score 7.5, 95% CI 6.935-7.969 -12 months mean score 7.8, Intervention (baseline mean score 7.3, 95% CI 6.810-7.880 -12 months mean score 7.8, 95% CI 7.142-8.477); Control (baseline mean score 7.5, 95% CI 6.935-7.969 -12 months mean score 7.8, 95% CI 7.145-8.436) Intervention (baseline mean score 8.0, 95% CI 6.99 -9.04 -12 months mean score 9.6, 95% CI 8.437-10.749); Control (baseline mean score 8.5, 95% CI 7.554-9.529 -12 months mean score 8.0, 95% CI 6.877-9.113) Intervention ( Intervention mean score (month 1, 6.38 (SD 1.47) -month 4, 6.54 (SD 1.33); Control mean score (month 1, 6.65 (1.36) -month 4, 6.77 (SD 1.31)) - Intervention (baseline mean score 9.77 (SD±5.41) -6 months mean score 13.28 (SD±4.21)); Control (baseline mean score 9.93 (SD±2.273)-6 months mean score 11.33 (SD±3.11)) Intervention (baseline mean score 10.25 (SD±5.30 -12 months mean score 11.19 (SD±4.07); Control (baseline mean score 9.63 (SD±2.46 -12 months mean score 10.43 (SD±3.51))  -
